Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study (TRuST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02875548
Recruitment Status : Recruiting
First Posted : August 23, 2016
Last Update Posted : January 10, 2019
Sponsor:
Information provided by (Responsible Party):
Epizyme, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : April 2024